Tong Ren Tang Healthcare raises HK$532 million in Hong Kong IPO
Beijing Tong Ren Tang Healthcare Investment Co. Ltd. commenced trading on the Hong Kong stock exchange on July 7 after raising HK$532 million. The IPO priced 108 million shares at HK$5.50 each, with cornerstone investors backing half of the offering. The firm intends to deploy 64% of the funds to expand its network of medical facilities and consolidate the traditional Chinese medicine market.
*this image is generated using AI for illustrative purposes only.
Beijing Tong Ren Tang Healthcare Investment Co. Ltd. raised HK$532 million ($68 million) in its Hong Kong trading debut on July 7, pricing its initial public offering (IPO) at HK$5.50 per share. The company sold 108 million shares, adopting a conservative pricing strategy after postponing its original March listing plan due to market uncertainty. A majority of the proceeds will be used to expand its network of traditional Chinese medicine (TCM) hospitals and clinics, aiming to consolidate the fragmented market.
Cornerstone investors, including Airport Port Technology Capital, Aurora SF and CICCFT, purchased HK$296.1 million of the IPO shares, representing about 50% of the total on offer. The company has also deployed stabilization dealers to support the share price in early trading if it falls below the offer level. Tong Ren Tang Healthcare ranks as China's largest private TCM operator by patient visits, with annual visits growing 39.4% on average.
Financial Performance
The company's financials show stable revenue with a decline in profit for the recent year. Revenue stood at 1.17 billion yuan, almost unchanged from 1.18 billion yuan the previous year. Healthcare services accounted for 85% of revenue, rising to 995 million yuan from 988 million yuan. Product sales fell to 150 million yuan from 167 million yuan.
| Metric | Value (2025) | Value (2024) |
|---|---|---|
| Revenue | 1.17 billion yuan | 1.18 billion yuan |
| Healthcare Services Revenue | 995 million yuan | 988 million yuan |
| Product Sales Revenue | 150 million yuan | 167 million yuan |
| Profit | 33.8 million yuan | 46.2 million yuan |
| Gross Margin | 18.9% | N/A |
Profit fell to 33.8 million yuan from 46.2 million yuan in 2024. The company noted that the 2024 profit included a 17.1-million-yuan one-time gain from an asset sale that did not recur in 2025.
Operations and Expansion Strategy
Tong Ren Tang Healthcare operates 13 self-owned hospitals, outpatient healthcare centers and clinics, and provides management services for another 13. It also runs an internet hospital and cooperates with over 500 external pharmacies. The company plans to use about 64% of the listing proceeds to expand its network and enhance service capacity, including acquiring three to five medical institutions by the end of 2030.
The TCM market is projected to grow 9.5% annually between 2025 and 2030 to reach 1.7 trillion yuan ($251 million). The company aims to act as a consolidator, leveraging its 357-year brand heritage. Three of its self-owned facilities were acquired since 2022, including two in Shanghai in 2024, focusing on affluent regions like the Yangtze River Delta.
How will the company address the declining profit margins while executing an aggressive expansion strategy?
What specific criteria will be used to select the three to five medical institutions targeted for acquisition by 2030?
Can the internet hospital and external pharmacy partnerships sustain revenue growth if physical expansion faces delays?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
